1989
DOI: 10.1021/jm00126a005
|View full text |Cite
|
Sign up to set email alerts
|

Cardiotonic agents. 5. Fragments from the heterocycle-phenyl-imidazole pharmacophore

Abstract: To examine the role of each component in the heterocycle-phenyl-imidazole inotropic pharmacophore, several imidazolone derivatives, an arylimidazole, a substituted 3,4-dihydro-4-oxopyrimidine, and a quinolin-2(1H)-one derivative were prepared as structural fragments or representatives from this relationship. Tests for cardiac inotropic activity in ferret papillary muscle strips (FPM) and for inhibition of crude cAMP phosphodiesterase obtained from canine cardiac tissue suggest that, while all three components … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
10
0
1

Year Published

1991
1991
2021
2021

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 25 publications
(12 citation statements)
references
References 1 publication
1
10
0
1
Order By: Relevance
“…Thus, CK-2289 is a direct acting, positive inotropic agent in the pentobarbital-anesthetized dog. Similar conclusions can be reached for milrinone and enoxi- [Weishaar et al, 1985a[Weishaar et al, ,b, 1986aAlousi and Johnson, 1986;Erhardt et al, 1989;Harris et al, 19891. CK-2289, milrinone, and enoximone inhibit type I11 cyclic adenosine monophosphate (CAMP) phosphodiesterase (PDE) obtained from canine, guinea pig, and ferret heart and vascular smooth muscle, in vitro [Weishaar et al, 1985a[Weishaar et al, ,b, 1986a[Weishaar et al, ,b, 1987Ahn et al, 1986;Alousi and Johnson, 1986;Earl et al, 1986a;Erhardt et al, 1989;Harris et al, 19891 and CAMP-dependent protein kinase [Earl et al, 1986bl.…”
Section: Discussionsupporting
confidence: 60%
See 1 more Smart Citation
“…Thus, CK-2289 is a direct acting, positive inotropic agent in the pentobarbital-anesthetized dog. Similar conclusions can be reached for milrinone and enoxi- [Weishaar et al, 1985a[Weishaar et al, ,b, 1986aAlousi and Johnson, 1986;Erhardt et al, 1989;Harris et al, 19891. CK-2289, milrinone, and enoximone inhibit type I11 cyclic adenosine monophosphate (CAMP) phosphodiesterase (PDE) obtained from canine, guinea pig, and ferret heart and vascular smooth muscle, in vitro [Weishaar et al, 1985a[Weishaar et al, ,b, 1986a[Weishaar et al, ,b, 1987Ahn et al, 1986;Alousi and Johnson, 1986;Earl et al, 1986a;Erhardt et al, 1989;Harris et al, 19891 and CAMP-dependent protein kinase [Earl et al, 1986bl.…”
Section: Discussionsupporting
confidence: 60%
“…Inhibition of cAMP PDE may also account for the vasodilator and positive chronotropic effects of CK-2289, milrinone, and enoximone. The relative potencies of milrinone and other compounds as inhibitors of cardiac and vascular smooth muscle cAMP PDE differ [Weishaar et al, 1985a[Weishaar et al, ,b, 1986aErhardt et al, 1989;Harris et al, 19891. This may reflect the 1) different isomeric forms of cAMP PDE in cardiac and smooth muscle, and 2) similarities between the compounds as positive inotropes despite the differences in relative potency as vasodilator agents.…”
Section: Discussionmentioning
confidence: 99%
“…Imidazole is of great significance as a ligand due to its presence in many biological systems (such as amino acids histidine and purines, enzymes) and providing a potential binding site for metal ions (Edsall et al, 1954;Brooks andDavidson 1960, Mighell andSantoro, 1971). Imidazole and its derivatives have become an important part of many pharmacological activities such as, analgesic, anti-inflammatory (Suzuki et al, 1992), anti-anthelmintic (Lunt et al, 1987), anti-fungal (Johnson et al, 1999), antitubercular (Pandey et al, 2009), antimicrobial (Vijesh et al, 2013), anticancer (Miyachi et al, 1998) and cardiovascular (Erhardt et al, 1989) activities. Except their pharmacological effects, they also function as catalysts (Jencks, 1970) and polymerizing agents (Samdal and Møllendal, 2011) for example 1vinylimidazole (vim) ( Figure 1) is used as a copolymerization agent in the production of cationic polymers (Ebel et al, 2000).…”
Section: Introductionmentioning
confidence: 99%
“…The N-arylazoles and biarylethers are among the most commonly found motifs in pharmaceuticals, biologically active molecules, crop-protection chemicals, and material science. A huge number of drugs contain N-arylimidazole moieties including cyclic AMP phosphodiesterase inhibitors (Sircar et al, 1987; Venuti et al, 1988; Güngör et al, 1992; Martinez et al, 1992; Sawanishi et al, 1997), thromboxane synthase inhibitors (Iizuka et al, 1981; Martinez et al, 1992; Cozzi et al, 1993; Nicolaï et al, 1993), topical antiglaucoma agents (Lo et al, 1992), and cardiotonic agents (Hagedorn et al, 1987; Erhardt et al, 1989; Shaw et al, 1992). In this regard, transition-metal catalyzed C-heteroatom coupling reactions have become one of the most important areas in modern chemical synthesis.…”
Section: Introductionmentioning
confidence: 99%